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4-111iazolidinones 48-0, 58-0 have been synthesised by the
cyclocondensation of different schiff's bases 3a-o with
thioglycolic acid and thiolactic acid respectively. All the
compounds were screened for their antitubercular activity
against Mycobacterium tuberculosis H37 Rv.
4- Thiazolidinones are endowed a variety of
biological activities 1-5 Further, paracetamol deri-
vatives have been found to exhibit the therapeutic
activity'". In order to explore the activities
associated with this nucleus, we report herein the
synthesis and antitubercular activity of the
derivatives of thiazolidinone.
The reaction of p-hydroxy acetanilide with ethyl
chloro acetate in the presence of dry acetone and
anhyd. K2C03 gave the desired ethyl p-acetamido-
phenoxy- acetate" 1 which was converted to p-
acetamidophenoxy acetyl hydrazide" 2 by treatment
with a slight excess of hydrazine hydrate in absolute
ethanol under reflux. The hydrazide 2 was
.condensed with different araldehydes to obtain
corresponding NI -substituted benzal, N2 -p-aceta-
midophenoxy acyl hydrazines 3a-o (schiffs bases).
These different schiffs bases were cyclocondensed
with thioglycolic acid and thiolactic acid to afford
respective 2-aryl-3-p-acetamidophenoxy acetamido-
5-H-4-thiazolidinones 4a-o and 2-aryl-3-p-aceta-
midophenoxy acetan1ido-5-methyl-4-thiazolidinones
5a-o (Scheme I).
The structure of the compounds synthesised were
assigned on the basis of elemental analyses, JR, lH
NMR and mass spectral data. The compounds were
evaluated for antitubercular activity towards a
strain of Mycobacterium tuberculosis H37 Rv.
Note
0-0-\I r;
H3C - C . HN ~ OH + CICH COOC H
2 2 5
o -0- 0\I II




1 NH? Nil:> 11,,0
H3C . g -HN-{ ')- OCH
2
g· NH - NH2
(2)1 R-CHO
o -0- 0II II
H3C - C - HN r;_ ~ OCH
2
C . NH . N = CH . R
(3a-o)1 SH.?H-COOH
X
x = C113. n ~ Alyl
Scheme I
Antitubercular activity
The antitubercular evaluation of the compounds
was carried out at Tuberculosis Antimicrobial
Acquisition Co-ordinating Facility (T AACF) USA.
Primary screening of the compounds for antituber-
cular activity have been conducted at 12.5 ug/ml
against Mycobacterium tuberculosis H37 Rv in
BACTEC 12B medium using the BACTEC 460
radiometric system.
All the compounds are reported in Table J for
their antitubercular activity data. It can be con-
cluded from Table-I that compounds 3a-o and 5a-
o exhibited various degree of activity (0 to 35%)
whereas compounds 4a-o were inactive.
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Table 1-Physical constants and antitubercular activity data of compounds 3a-o, 4a-o and 5a-o.
N(%) %of
Compd R Mol. formula m.p.("C) YieJd(%) Found Caled. inhibition"
38 -CJIs- CI7HI7N)03 212 52 13.58 13.50 17
3b 2-CI-CJ-L- C17HloN303CI 205 54 12.24 12.15 35
3c 4-CI-CJ-L- CI7H1oN3O)CI 200 58 12.21 12.15 29
3d 2,4-CI2-CJI3- CJ7H1sN303C12 230 60 11.10 11.05
3e 3,4-( OCH3 )2-CJI3- CI9H21N30S 205 57 11.25 11.32
3f 4-N,N-(CH3)2-C6H4- CI9HnN403 220 62 18.75 18.81 20
3g CJ·hO- CisHIsN304 195 63 13.90 13.95 15
3h 2-0H-CJ-L- CJ7HJ7N304 228 65 12.80 12.84
3i 4-0H-CJ-L- CJ7HJ7N304 155 61 12.78 12.84
3j 4-OCH3-CJI4- C1sHI9N304 208 58 12.25 12.31 25
3k 3-(OCH3)-4-(OH)-CoH3- CIsHI9N30S 225 62 11.70 11.76
31 2-N02-CJ14- CI7HloN40S 255 58 15.79 15.73 09
3m 3-N02-C6H4- CI7HloN40S 232 60 15.79 15.73
3n -CH=CH-C6Hs CI9HI9N303 234 55 12AO 12.46 04
30 3,4,5-(OCH3)J-CoH2- C2oH2)N306 200 57 10Al 10.47 01
43 CJIs- CI9HI9N304S 218 50 10.80 10.90 00
4b 2-CI-C6H4- C 19H1sN304SCI 210 48 10.10 1001 00
4c 4-CI-C6H4- CI9H1sN304SCI 250 45 10.11 10.01 00
4d 2,4-Ch-CoH3- C 19HI7N304SCh 205 47 9.20 9.25 00
4e 3,4-(OCH3)2-C6H3- C21H2)N30oS 290 41 9.38 9.43 00
4f 4-N,N(CH3)2-C6H4- C2IH2~40.IS 320 44 13.12 13.08 00
4g CM3O- CJ7HI7N30SS 265 47 11.28 11.20 00
4h 2-0H-CoH4- CI9HI9N)OsS 241 46 9.68 9.74 00
4i 4-0H-CoH4- CI9HI9N30SS 245 49 10Al 10.47 00
4j 4-0CH3-CoH4- C2oH2IN30SS 175 49 10.19 10.12 00
4k 3-(OCH3)-4-(OH)-C6H3- C2oH2IN306S 212 49 9.70 9.74 00
41 2-N02-CoH4- CI9H1sN406S 205 40 13.10 13.02 00
4m 3-N02-C6H4- CI9H1sN4OoS 207 41 13.12 1302 00
4n -CH=CI-I-C6I-1S Cl11-I11N304S 270 40 10.15 10.21 00
40 3,4,5-(OCI-I3h-C61-11- C211-12sN307S 210 42 8.80 8.84 00
5a C61-1s- C2ol-bN304S 215 45 10A5 10.52 00
5b 2-CI-C61-14- Clol-lzoN304SCI 105 42 9.61 9.68 00
5c 4-CI-C61-14- C lol-hoN304SCI 207 44 9.59 9.68 00
5d 2,4-CIz-C61-13- C201-119N304SCIz 198 47 8.91 8.97 00
5e 3,4-(OCI-I3)2-CoI-l3- C121-12sN)OoS 102 49 9.19 9.15 00
5f 4-N,N(CI-I3)z-CoI-l4- CdbN404S 225 45 12.70 12.66 00
5g CM3O- C ISl-l19N30SS 265 46 10.83 10.79 00
5h 2-01-l-CoI-l4- C1Ol-l21N30SS 201 43 10.06 10.12 00
5i 4-01-l-C61-14- C1OI-I1IN3OsS 207 42 1008 10.12 00
5j 4-0CI-I3-C6H4- Clll-l2)N3OSS 300 48 9.72 9.79 28
5k 3-(OCI-I3)-4-(OH)-C,,/b- C2IH23N)OoS 168 45 9A7 9.43 24
51 2-N02-C61-14- C2ol-hoN40oS 178 47 12.54 12.61 27
5m 3-NOrC6H4- C1o/-izoN40"S 108 45 12.56 12.61 27
5n -CI-I=CI-I-Col-Is Clll-l2)N30.IS 218 42 9.80 9.88 18
50 3,4,5-(OCI-I3»)-CoI-l2- C2)/--\z7N307S 162 43 8.52 8.57 27
* Mycobacterium Tuberculosis J/37 Rv
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Experimental Section
All the melting points are uncorrected. Infrared
spectra were recorded on Shimadzu 435-IR
spectrophotometer, IH NMR spectra on Brucker-
300F MHz spectrophotometer using TMS as an
internal standard and mass spectra on Jeol Jms 0-
300 spectrophotometer.
NI-4-Methoxy benzal, N2 -p-acetamidophenoxy-
acyl hydrazine 3j. A mixture of 2 (0.01 mole) and
4-methoxy benzaldehyde (0.015 mole) was refluxed
in absolute ethanol for 5-6 h. The contents were
cooled and poured onto crushed ice and triturated
with sodium bisulphite solution. The product was
isolated and crystallised from dioxane to give 3j,
yield 58%, m.p. 208° (Found : C, 63.39; H, 5.50,
N, 12.25. CI8HI9N304 requires C, 63.34; H, 5.57,
N, 12.31%); IR (KBr) ; 3300 (N-H), 1680 (C=O),
1660 (C=O of ~NHCOCH3), 1585 (C=N), 1245 (C-
O-C sym.) 1030 cm-I(C-O-C asym.); IH NMR
(TF A + DMSO-d6); 0 2.52 (s, 3H, -COCH3), 4.07
(s, 3H, -OCH3), 4.94 (s, 2H, -OCH2), 7.12-7.29 (m,
8H, Ar-H), 7.7 (s,IH, CH=N), 8.1 (s, IH, -NH-N);
MS : mJz 342 (~), 279, 237, 233, 223, 208, 203,
197, 191, 175, 165, 119, 108,91 and 77.
Compounds 3a-o were prepared similarly and
the physical data are given in Table I.
2-(4' -Methoxy phenyl)-3-p-acetamidophenoxy
acetamido-5-H/methyl-4-thiazolidinones 4j, 5j. A 2
mixture of 3j (0.01 mole) and thioglycolic acid! 3
thiolactic acid (0.01 mole) was heated on an oil-bath
at 120-25°C for 12 h. The reaction mixture was 4
cooled and treated with 10% sodium bicar-bonate
solution. The product was isolated and crystallised
from ethanol.
4j : Yield 49%, m.p. 175° (Found: C, 57.60; H,
5.01, N, 10.19. C2oH21N30SSrequires C, 57.83; H,
5.06, N, 10.12%); IR (KBr) : For 4a, 3300 (N-H),
1700 (C=O thiazolidinone moiety),1670 (C=O),
1660 (C=O of -NHCOCH3), 1275 (C-O-C sym.)
605 cm-I(C-S-C); IH NMR (CDCh + DMSO-d6); 0
2.56 (s, 3H, -COCH3), 3.82 (s, 2H, -CHz-CO), 4.95
(s, 2H, -OCH2), 5.96 (m, IH, -S-CH-Ar), 6.9-7.6
(m, 9H, Ar-H), 8.1 (s,IH, -NHCO), 8.31 (s, lH, -
NH-N) MS : For 4e : mJz 446 (~), 308, 247, 233,
191, 174, 165, 159, 134, 121 and 77.
5j : Yield 48%, m.p. 300° (Found : C, 58.62; H,
5.39, N, 9.74. C21H23N30SSrequires C, 58.74; H,
5.36, N, 9.79%); IR (KBr) : 3300 (N-H), 1715
(C=O thiazolidinone moiety),1680 (C=O), 1660
(C=O of -NHCOCH3), 1225 (C-O-C sym.) 1055
(C-O-C asym.) 700 cm-I(C-S-C); IH NMR (CDCh
+TFA); 0 1.70-1.72 (d, 3H, -CH-CH3), 2.35 (s, 3H,
-COCH3), 3.88 (s, 3H, -OCH3), 4.20 (q, IH, -CH-
CH3), 4.81 (S, 2H, -OCH2); 5.96 (s, lH, -S-CH-Ar)
6.93-7.68 (m, 8H, Ar-H), 8,32 (s, lH, -NH-N).
Compounds 4a-o and 5a-o were prepared
similarly and the physical data are given in Table I.
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